MedPath

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

Phase 2
Completed
Conditions
Severe Hypertriglyceridemia
Interventions
Drug: Placebo
Registration Number
NCT04720534
Lead Sponsor
Arrowhead Pharmaceuticals
Brief Summary

The purpose of AROAPOC3-2001 is to evaluate the efficacy and safety of ARO-APOC3 in participants with severe hypertriglyceridemia. Participants will receive 2 subcutaneous injections of ARO-APOC3.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
229
Inclusion Criteria
  • Based on medical history, evidence of TG ≥ 500 mg/dL and ≤ 4000 mg/dL at Screening
  • Fasting TG ≥ 500 mg/dL at Screening
  • Willing to follow diet counseling per Investigator judgment based on local standard of care
  • Women of childbearing potential must have a negative pregnancy test, cannot be breastfeeding, and must be willing to use contraception
  • Willing to provide written informed consent and to comply with study requirements
Exclusion Criteria
  • Active pancreatitis within 12 weeks prior to first dose
  • Any planned bariatric surgery or similar procedures to induce weight loss from consent to end of study
  • Acute coronary syndrome event within 24 weeks of first dose
  • Major surgery within 12 weeks of first dose
  • Planned coronary intervention (e.g., stent placement or heart bypass) or any non-cardiac major surgical procedure throughout the study
  • Uncontrolled hypertension
  • Human immunodeficiency virus (HIV) infection, seropositive for Hepatitis B (HBV), seropositive for Hepatitis C (HCV)
  • Uncontrolled hypothyroidism or hyperthyroidism
  • Hemorrhagic stroke within 24 weeks of first dose
  • Malignancy within the last 2 years prior to date of consent requiring systemic treatment (some exceptions apply)

Note: additional inclusion/exclusion criteria may apply per protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo, Day 1 and Week 12Placebocalculated volume to match active treatment by sc injection
ARO-APOC3 10 mg, Day 1 and Week 12ARO-APOC32 doses of ARO-APOC3 by subcutaneous (sc) injection
ARO-APOC3 50 mg, Day 1 and Week 12ARO-APOC32 doses of ARO-APOC3 by sc injection
ARO-APOC3 25 mg, Day 1 and Week 12ARO-APOC32 doses of ARO-APOC3 by sc injection
Primary Outcome Measures
NameTimeMethod
Percent Change from Baseline in Fasting Triglycerides (TG) at Week 24Baseline, Week 24
Secondary Outcome Measures
NameTimeMethod
Percent Change from Baseline in Fasting Total Apolipoprotein B (ApoB) at Week 24Baseline, Week 24
Percent Change from Baseline in Apolipoprotein (Apo)C-III at Week 24Baseline, Week 24
Percent Change from Baseline in Fasting High-Density Lipoprotein-Cholesterol (HDL-C) at Week 24Baseline, Week 24
Percent Change from Baseline in Fasting Total ApoB Over Time Through Week 48Baseline, up to Week 48
Percent Change from Baseline in Fasting TG Over Time Through Week 48Baseline, up to Week 48
Percent Change from Baseline in ApoC-III Over Time Through Week 48Baseline, up to Week 48
Percent Change from Baseline in Fasting Non-HDL-C Over Time Through Week 48Baseline, up to Week 48
Percent Change from Baseline in Fasting HDL-C Over Time Through Week 48Baseline, up to Week 48
Change from Baseline in Plasma Concentration of ARO-APOC3 Over Time Through Week 48Baseline, up to Week 48
Percent Change from Baseline in Fasting Non-High-Density Lipoprotein-Cholesterol (Non-HDL-C) at Week 24Baseline, Week 24
Percent Change from Baseline in Fasting Low-density Lipoprotein-Cholesterol (LDL-C) Using UltracentrifugationBaseline, Week 24
Percent Change from Baseline in Fasting LDL-C Using Ultracentrifugation Over Time Through Week 48Baseline, up to Week 48
Number of Participants with Adverse Events (AEs) and/or Serious Adverse Events (SAEs) Possibly or Probably Related to Treatmentup to Week 48

Trial Locations

Locations (74)

Pioneer Research Solutions, Inc.

🇺🇸

Houston, Texas, United States

Clinical Research of South Nevada

🇺🇸

Las Vegas, Nevada, United States

AppleMed Research Group

🇺🇸

Miami, Florida, United States

HeartWell LLP

🇺🇸

Miami, Florida, United States

BFHC Research

🇺🇸

San Antonio, Texas, United States

Debreceni Egyetem

🇭🇺

Debrecen, Hungary

Medifarma-98 Kft.

🇭🇺

Nyíregyháza, Hungary

Glacier View Research Institute

🇺🇸

Kalispell, Montana, United States

NZOZ TWOJE ZDROWIE EL Sp.z.o.o.

🇵🇱

Elbląg, Poland

KO-MED M Konieczny Cent. Wielosp. Opieki

🇵🇱

Puławy, Poland

Centre d'Etudes Cliniques ECOGENE-21

🇨🇦

Chicoutimi, Quebec, Canada

Institut de Recherches Cliniques de Montreal

🇨🇦

Montréal, Quebec, Canada

Lausmed Kft.

🇭🇺

Baja, Hungary

Principal SMO Kft

🇭🇺

Baja, Hungary

Belgyogyaszati - Kardiologiai Maganrendelo

🇭🇺

Bekescsaba, Hungary

WR-CllinSearch, LLC

🇺🇸

Chattanooga, Tennessee, United States

Praktyka Lekarska Ewa Krzyzagorska

🇵🇱

Poznań, Poland

Centrum Medyczne K2J2

🇵🇱

Wołomin, Poland

Centrum Medyczne Medyk

🇵🇱

Rzeszów, Poland

Monash Health

🇦🇺

Clayton, Victoria, Australia

Albert Schweitzer Ziekenhuis

🇳🇱

Dordrecht, Netherlands

Indywidualna Specjalistyczna Praktyka Lekarska w Dziedzinie Kardiologii lek.

🇵🇱

Gdynia, Poland

Medicome Sp. z.o.o.

🇵🇱

Oświęcim, Poland

Methodist Physicians Clinic Heart Consultants

🇺🇸

Omaha, Nebraska, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Preventive Cardiology Inc.

🇺🇸

Boca Raton, Florida, United States

A Positive Research, Inc.

🇺🇸

Miami, Florida, United States

Mid Hudson Medical Research, PLLC

🇺🇸

New Windsor, New York, United States

PriMed Clinical Research

🇺🇸

Dayton, Ohio, United States

Tribe Clinical Research

🇺🇸

Greenville, South Carolina, United States

Icahn School of Medicine at Mount Sinai (ISMMS)

🇺🇸

New York, New York, United States

Lucas Research, Inc

🇺🇸

Morehead City, North Carolina, United States

Prestige Clinical Research

🇺🇸

Franklin, Ohio, United States

Lillestol Research LLC

🇺🇸

Fargo, North Dakota, United States

South Oklahoma Heart Research, LLC

🇺🇸

Oklahoma City, Oklahoma, United States

Advanced Medical Research, LLC

🇺🇸

Maumee, Ohio, United States

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

LMC Diabetes & Endocrinology

🇨🇦

Concord, Ontario, Canada

LMC Manna Research - Bayview

🇨🇦

Toronto, Ontario, Canada

ViaCar Recherches Cliniques Inc.

🇨🇦

Greenfield, Quebec, Canada

Universitatsklinikum Leipzig

🇩🇪

Leipzig, Germany

Selye Janos Korhaz

🇭🇺

Komárom, Hungary

Pharma4trial Ltd

🇭🇺

Gyöngyös, Hungary

Borbanya Praxis Kft.

🇭🇺

Nyiregyhaza, Hungary

Westside Medical Associates of Los Angeles

🇺🇸

Beverly Hills, California, United States

Y&L Advance Health care, Inc. D/B/A Elite Clinical Research

🇺🇸

Miami, Florida, United States

Desert Oasis Healthcare (Desert Medical Group, Inc.)

🇺🇸

Palm Springs, California, United States

Ocean Blue Medical Research Center Inc.

🇺🇸

Miami Springs, Florida, United States

Alta Pharmaceutical Research Center

🇺🇸

Dunwoody, Georgia, United States

The Research Group of Lexington, LLC

🇺🇸

Lexington, Kentucky, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Invesclinic U.S., LLC

🇺🇸

Fort Lauderdale, Florida, United States

Cardiology Associates Research, LLC

🇺🇸

Tupelo, Mississippi, United States

Progressive Medical Research

🇺🇸

Port Orange, Florida, United States

NYC Research, Inc.

🇺🇸

Long Island City, New York, United States

Northwest Heart Clinical Research

🇺🇸

Arlington Heights, Illinois, United States

Linear Clinical Research

🇦🇺

Perth, Nedlands, Australia

Manassas Clinical Research Center

🇺🇸

Manassas, Virginia, United States

Royal Prince Alfred Hospital

🇦🇺

Camperdown, New South Wales, Australia

University of the Sunshine Coast

🇦🇺

Sippy Downs, Queensland, Australia

Core Research Group

🇦🇺

Brisbane, Queensland, Australia

Lawson Health Research Institute

🇨🇦

London, Ontario, Canada

Uniklinik RWTH

🇩🇪

Aachen, Germany

DRC Gyogyszervizsgalo Kozpont Balatonfured

🇭🇺

Balatonföldvár, Hungary

Lakeland Clinical Trials - Waikato

🇳🇿

Hamilton, New Zealand

Uni Van Amsterdam Academisch Medisch Centrum

🇳🇱

Amsterdam, Netherlands

D&A Research

🇳🇱

Sneek, Netherlands

Lipid and Diabetes Research Group

🇳🇿

Christchurch, New Zealand

Middlemore Clinical Trials

🇳🇿

Papatoetoe, New Zealand

Auckland Clinical Studies

🇳🇿

Grafton, Auckland, New Zealand

Spolka Lekarzy Intercor Sp.z.o.o.

🇵🇱

Bydgoszcz, Poland

Lakeland Clinical Trials - Rotorua

🇳🇿

Rotorua, New Zealand

Zaklad Opieki Zdrowotnej Leczyca

🇵🇱

Leczyca, Poland

All-MED Centrum Medyczne

🇵🇱

Łódź, Poland

© Copyright 2025. All Rights Reserved by MedPath